Mostrando 2 resultados de: 2
Filtros aplicados
Subtipo de publicación
Article(2)
Publisher
Archivos Venezolanos de Farmacologia y Terapeutica(1)
Revista Latinoamericana de Hipertension(1)
Año de Publicación
2020(2)
Origen
scopus(2)
Dapagliflozin - knocking down barriers in the current treatment of diabetes mellitus
ArticleAbstract: Diabetes mellitus (DM) is associated with a high degree of morbidity and premature mortality, a subsPalabras claves:Dapagliflozin, diabetes mellitus, Efficacy, SGLT2 inhibitors, TolerabilityAutores:Bohórquez F.B., Dávila C.S., Gavilanes A.P., Intriago J.A., María Belén Gutiérrez Yépez, Nadia Neida Shiguango, Ortiz C.G., Pilataxi N.E.Fuentes:scopusCanaaliflozin integrando la evidencia clinica actual canagliflozin: Integrating current clinical evidence
ArticleAbstract: SGLT2 inhibitors (SGLT2i) have profoundly marked the aca-demics and practice in the field of endocriPalabras claves:Adverse effects, Canagliflozin, Clinical evidence, diabetes mellitus, EfficacyAutores:Alicia De Los Ángeles Morocho-Zambrano, Cajas G.M., Cobo L.C., Gutierrez Yepez M.B., Intriago J.A., Jhersson Rivadeneira Campoverde, Piiataxi N.E., Yugsi R.A.Fuentes:scopus